Work

Immune Checkpoint Inhibitors in Metastatic Renal Cell Carcinoma With Sarcomatoid Dedifferentiation: A Multicenter Retrospective Study

Year: 2026

Type: article

Study design: Observational Study

Source: Journal of the National Comprehensive Cancer Network

DOI: 10.6004/jnccn.2026.7058

Authors: Dharmesh Gopalakrishnan, Yu Fujiwara, Katharine A. Collier, Joseph J. Park, Jacob P. Zaemes, Elaine T. Lam, Sabah Alaklabi, Ellen B. Jaeger, Pedro C. Barata, Eric C. Kauffman, Michael B. Atkins, Ajjai Alva, Yuanquan Yang, Saby George

Institutions: Roswell Park Comprehensive Cancer Center, Cleveland Clinic Abu Dhabi, Medical College of Wisconsin Cancer Center, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Duke University, U-M Rogel Cancer Center, Duke Cancer Institute, Beth Israel Deaconess Medical Center, University of Colorado Cancer Center, Tulane University, Case Comprehensive Cancer Center, Georgetown University Medical Center, Georgetown Lombardi Comprehensive Cancer Center

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7221697303

FWCI:

Cites:

Cited by:

Related to: